Entera Bio Ltd-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Entera Bio Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011876
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Entera Bio Ltd (Entera Bio) is a clinical-stage biopharmaceutical company that offers development and commercialization of a novel drug delivery platform for bone healing. The company develops novel drug delivery platform for oral delivery of large molecule protein active pharmaceutical ingredients. It conducts clinical trials of three candidate drugs based on applying Entera’s technology to teriparatide for the treatment of hypoparathyroidism, osteoporosis, and bone healing. The company also offers clinical trial programs and orphan drug designation for hypoparathyroidism. Entera Bio is headquartered in Jerusalem, Israel.

Entera Bio Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Entera Bio Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Entera Bio Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Entera Bio Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Entera Bio Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Entera Bio Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Entera Bio Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Entera Bio Raises USD2 Million in Venture Financing 10
Entera Bio Plans to Raise USD10 Million in Venture Financing 11
Equity Offering 12
Entera Files Registration Statement to Raise Funds through Public Offering of Shares 12
Entera Bio Files Registration Statement for IPO of Shares for up to USD50 Million 13
Acquisition 14
D.N.A Biomedical Completes Acquisition Of 47% JV Stake In Entera Bio From Oramed For US$1 Million 14
Entera Bio Ltd – Key Competitors 15
Entera Bio Ltd – Key Employees 16
Entera Bio Ltd – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Corporate Communications 18
Mar 28, 2016: EnteraBio: New Director – Roger L. Garceau 18
Product Approvals 19
Jun 29, 2016: EnteraBio Receives Orphan Drug Approval for PTH 1-34 from European Medicines Agency 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Entera Bio Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Entera Bio Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Entera Bio Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Entera Bio Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Entera Bio Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Entera Bio Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Entera Bio Raises USD2 Million in Venture Financing 10
Entera Bio Plans to Raise USD10 Million in Venture Financing 11
Entera Files Registration Statement to Raise Funds through Public Offering of Shares 12
Entera Bio Files Registration Statement for IPO of Shares for up to USD50 Million 13
D.N.A Biomedical Completes Acquisition Of 47% JV Stake In Entera Bio From Oramed For US$1 Million 14
Entera Bio Ltd, Key Competitors 15
Entera Bio Ltd, Key Employees 16

★海外企業調査レポート[Entera Bio Ltd-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Mediaset SpA (MS):企業の財務・戦略的SWOT分析
    Mediaset SpA (MS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • PHINMA Energy Corp (TAPET):企業の財務・戦略的SWOT分析
    Summary PHINMA Energy Corp (PHINMA), formerly Trans-Asia Oil and Energy Development Corp, is an oil and gas company that explores and develops oil and gas interest and geothermal energy. The company operates through business division such as power, wind energy, and energy resource development. Its p …
  • Aspire Health Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Aspire Health Inc (Aspire) is a healthcare company which operates a network of outpatient palliative care practices providing medical care for patients with relief from the symptoms, pain, and stress of a serious illness. Its service offerings include symptom and disease management, in-home …
  • Mannatech Inc (MTEX):企業の財務・戦略的SWOT分析
    Mannatech Inc (MTEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Dyo Boya Fabrikalari Sanayi ve Tic. A.S. (DYOBY):企業の財務・戦略的SWOT分析
    Dyo Boya Fabrikalari Sanayi ve Tic. A.S. (DYOBY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key s …
  • Pampa Energia SA (PAMP):石油・ガス:M&Aディール及び事業提携情報
    Summary Pampa Energia SA (Pampa) is an independent integrated energy company. It generates, distributes and transmits electricity; and explores and produces, refines oil and gas, and petrochemicals and commercializes and transports them. The company produces electricity using coal, wind, hydro, and …
  • InVivoScribe Technologies Inc-医療機器分野:企業M&A・提携分析
    Summary InVivoScribe Technologies Inc (InVivoScribe) is a provider of hematology-oncology testing products and services. The company’s products include lymphotrack and lymphotrack DX assay kits, and custom assay and reagent development products. It also provides general purpose reagents such as PCR …
  • Stora Enso Oyj (STERV):企業の財務・戦略的SWOT分析
    Stora Enso Oyj (STERV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Selecta Biosciences Inc (SELB):企業の財務・戦略的SWOT分析
    Summary Selecta Biosciences Inc (Selecta Biosciences) is a biopharmaceutical company that develops immunotherapies and vaccines for the treatment and prevention of human diseases. The company’s pipeline products include SEL-212, SEL-403, SEL-302 and SEL-302. It utilizes synthetic vaccine particle (S …
  • LaSalle Hotel Properties:企業のM&A・事業提携・投資動向
    LaSalle Hotel Properties - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's LaSalle Hotel Properties Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Soil Machine Dynamics Ltd:企業の戦略的SWOT分析
    Soil Machine Dynamics Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • China Metallurgical Group Corp (1618):企業の財務・戦略的SWOT分析
    China Metallurgical Group Corp (1618) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • GenomeDx Biosciences Inc-医療機器分野:企業M&A・提携分析
    Summary GenomeDx Biosciences Inc (GenomeDx) is a genomic information company developing solutions for prostate cancer treatment and the management of other urologic cancers. The company offers decipher prostate cancer classifier, a transformative genomic test that provides an assessment of tumor agg …
  • Step Pharma SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary Step Pharma SAS (Step Pharma) is a biotechnology company that strives to discover and develop proprietary small molecule medicines for the treatment of auto-immune diseases. The company is developing a new class of oral nucleotide synthesis inhibitors against cytidine triphosphate synthase 1 …
  • Mechel:企業の戦略・SWOT・財務情報
    Mechel - Strategy, SWOT and Corporate Finance Report Summary Mechel - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Eddie Stobart Logistics Plc
    Eddie Stobart Logistics Plc - Strategy, SWOT and Corporate Finance Report Summary Eddie Stobart Logistics Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Fujifilm SonoSite Inc:企業の戦略的SWOT分析
    Fujifilm SonoSite Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Highland Gold Mining Limited
    Highland Gold Mining Limited - Strategy, SWOT and Corporate Finance Report Summary Highland Gold Mining Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Spectrum Brands Holdings, Inc.:企業のM&A・事業提携・投資動向
    Spectrum Brands Holdings, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Spectrum Brands Holdings, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Cantel Medical Corp (CMD):企業の財務・戦略的SWOT分析
    Cantel Medical Corp (CMD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆